BetaEntity Annotation Prototype

Biomedical literature, made navigable

Follow the entities shaping the evidence.

Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.

Browse by entity family

An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.

View all families
29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed

Popular entities in these results

Choose an entity to see the articles in which it was identified.

Matching articles

29,499 articles · page 233 of 2459
moxifloxacinisoniazidlevofloxacinclofaziminebedaquilineStellenbosch UniversityMDR-TBHIVMultidrug-resistant tuberculosisUniversity of Cape Town+3 more

…fazimine, bedaquiline and the fluoroquinolones (levofloxacin or moxifloxacin). PK sampling will be divided as follows: 30 individuals will u…

rheumatoid arthritissystemic lupus erythematosusSjögren’s diseasesystemic sclerosismixed connective tissue diseaseundifferentiated connective tissue diseaseprimary anti-phospholipid syndromeSLERAEFPIA+5 more

…ease (MCTD), undifferentiated connective tissue disease (UCTD), rheumatoid arthritis (RA), primary anti-phospholipid syndrome (PAPS)), and 22 health…

hydroxychloroquineazathioprinemycophenolate mofetilClinic of Allergy and ImmunologySystemic lupus erythematosusUniversity Clinical Center of SerbiaSLEAPSInstitute of RheumatologySLE-DAS+1 more

…26]), with median FACIT-Fatigue 32 (18–43). Corticosteroids and hydroxychloroquine were most frequently used (85.5% and 81.7%), followed by azathi…